Atogepant 60 mg vs rimegepant and galcanezumab for episodic migraine prevention has superior efficacy, with comparable safety ...

STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive ...

For patients with MCI associated with Alzheimer disease, those in the highest tertile of the triglyceride-glucose index experience faster cognitive decline.

Most pediatric patients with migraine have normal imaging, supporting that routine scans rarely aid diagnosis or alter ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Noninvasive brain stimulation techniques, including transcranial direct current stimulation, are effective nonpharmacologic treatments for insomnia.

Sleep loss peaks in week 1 postpartum, then improves, but fragmented sleep persists for weeks, highlighting a key risk factor for postpartum health issues.

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

“Breast cancer survivors may have a slightly lower risk of AD compared with cancer-free individuals, potentially influenced by cancer treatments, underscoring the need for further research on ...

Once-daily rimegepant 75 mg is effective and well-tolerated for short-term prevention of fasting-related headache in adults ...

Galcanezumab shows similar pregnancy outcomes to placebo, highlighting the need for more real-world safety data in patients ...